Found 262 matching trials
A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
NAThis clinical trial tests how well a point of prostate cancer diagnosis (PP...
Location
Mayo Clinic in Florida
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
PHASE2The goal of this clinical research study is to compare how 2 different drug...
Location
Moffitt Cancer Center
Transition to Home (TtH) After Preterm Birth
NAPreterm birth is associated with significant and often life-long developmen...
Location
Universitätsklinik für Kinderheilkunde Neonatologie Inselspital
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19
PHASE3This phase III trial compares low dose whole lung radiation therapy to best...
Location
Emory University Hospital/Winship Cancer Institute
A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis
PHASE2This Phase 2 study is to be conducted to evaluate the safety, tolerability,...
Location
Pulmonary Associates, PA
Zalutumumab in Non-curable Patients With SCCHN
PHASE2Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study....
Location
University of Alabama at Birmingham
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
PHASE3The objective of this Phase III study is to evaluate the efficacy of ninted...
Location
1199.52.0108 Boehringer Ingelheim Investigational Site
Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners
PHASE1The goal of this clinical trial is to determine whether adding Integrated D...
Location
The Pennsylvania State University
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
PHASE3The purpose of this study is to compare the efficacy and safety of TAS-102 ...
Location
Arizona Center for Cancer Care
Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease
PHASE2The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Location
Multiple Locations